未登录 分享 收藏
Efficacy of Chemotherapy Following Prior PARP-Inhibitor Treatment in Patients with Ovarian Cancer 卵巢癌患者经PARP抑制剂治疗后化疗的疗效 Kim, Jung Chul; Park, Junsik; Lee, Yong Jae; Nam, Eun Ji; Kim, Sang Wun; Kim, Sung-Hoon; Kim, Young Tae; Kim, Se Ik; Kim, Jae-Weon; Kim, Byoung-Gie; Lee, Jung-Yun 分享 收藏
Efficacy and safety evaluation of a reusable advanced hemostatic device (Vi-Sealer) during total laparoscopic hysterectomy in South Korea (KGOG4009/Vi-TLH trial): study protocol for a multicenter, open-label, non-inferiority randomized controlled trial 韩国全腹腔镜子宫切除术中使用可重复使用的高级止血装置(Vi-Sealer)的疗效与安全性评估(KGOG4009/Vi-TLH试验)：一项多中心、开放标签、非劣效性随机对照试验的研究方案 Kim, Migang; Seong, Seok Ju; Kim, Kidong; Kim, Sang Wun; Park, Sung Taek; Kim, Woo Young; Choi, Youn Jin; Hong, Dae Gy; Park, Hyun 分享 收藏
HPK1 inhibitor reinvigorates exhausted tumor-infiltrating CD8+T cells and synergizes with anti-PD-1 inhibitor in endometrial cancer and ovarian cancer Park, Junsik; Lee, Yong Jae; Kim, Sunghoon; Lim, Seungmook; Park, A. Yeong; Eun Kim, Jamie Jae; Lee, Jinhwa; Kim, Sang Wun; Lee, Jung-Yun; Park, Su-Hyung 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Mismatch repair, p53, and L1 cell adhesion molecule status influence the response to chemotherapy in advanced and recurrent endometrial cancer 错配修复，p53和L1细胞粘附分子状态影响晚期和复发性子宫内膜癌对化疗的反应 Kim, Jung Chul; Ahn, Byungsoo; Lee, Yong Jae; Nam, Eun Ji; Kim, Sang Wun; Kim, Sunghoon; Kim, Young Tae; Park, Eunhyang; Lee, Jung-Yun 分享 收藏
分享 收藏
HPK1 inhibitor reinvigorates exhausted tumor-infiltrating CD8 T cells and synergizes with anti-PD-1 blockade in gynecologic malignancies Park, Junsik; Lee, Yong Jae; Kim, Sunghoon; Lim, Seungmook; Park, A. Yeong; Kim, Jamie Jae Eun; Lee, Jinhwa; Kim, Sang Wun; Park, Su-Hyung; Lee, Jung-Yun 分享 收藏
分享 收藏
Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial) 手术切除宫颈癌IIICr转移淋巴结的治疗效果: 一项III期多中心随机对照研究的试验方案 (KGOG1047/DEBULK试验) Yun, Bo Seong; Lee, Kwang-Beom; Lee, Keun Ho; Chang, Ha Kyun; Kim, Joo-Young; Lim, Myong Cheol; Choi, Chel Hun; Cho, Hanbyoul; Kim, Dae-Yeon; Kim, Yun Hwan; Choi, Joong Sub; Lee, Chae Hyeong; Kim, Jae-Weon; Kim, Sang Wun; Kim, Yong Bae; Cho, Chi-Heum; Hong, Dae Gy; Song, Yong Jung; Jeon, Seob; Kim, Min Kyu; Jeong, Dae Hoon; Park, Hyun; Kim, Seok Mo; Park, Sang-Il; Song, Jae-Yun; Mukhopadhyay, Asima; Dang Huy Quoc Thinh; Kampan, Nirmala Chandralega; Lee, Grace J.; Kim, Jae-Hoon; Eom, Keun-Yong; Roh, Ju-Won 分享 收藏
分享 收藏
Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer 使用肿瘤幼稚的下一代测序小组进行的连续循环肿瘤DNA分析可检测最小残留疾病并预测卵巢癌的结局 Heo, Jinho; Kim, Yoo-Na; Shin, Saeam; Lee, Kyunglim; Lee, Ji-Hyun; Lee, Yong Jae; Choi, Zisun; Park, Jihyang; Min, Seungki; Kim, Sang Wun; Choi, Jong Rak; Kim, Sunghoon; Lee, Seung-Tae; Lee, Jung-Yun 分享 收藏
Trial in progress: First-in-human phase I dose-escalation study of a novel Bicycle toxin conjugate (BT5528) targeting EphA2 in patients with advanced solid tumors Fontana, Elisa; Bashir, Babar; Wang, Judy S.; Aljumaily, Raid; Machiels, Jean-Pascal; Vieito, Maria; Falchook, Gerald; Carter, Louise; de Speville, Bernard Doger; Greystoke, Alastair; Kim, Sang Wun; Kotecki, Nuria; Spira, Alexander I.; Candilejo, Irene Moreno; Basu, Bristi; Prenen, Hans; Bessudo, Alberto; Nagasaka, Misako; Ahnert, Jordi Rodon; Park, Joo-Hwan; Teo, Min-Yuen; Rotow, Julia; Liu, Jie; De Rienzo, Assunta; Li, Mengyao; Domingo, Adriana; Orr, Hanna; Bennett, Gavin; Sharma, Rajiv; McKean, Meredith 分享 收藏
Frequency of peripheral PD-1+regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer 外周PD-1调节性T细胞的频率与上皮性卵巢癌患者对PARP抑制剂维持的治疗反应相关 Park, Junsik; Kim, Jung Chul; Lee, Miran; Lee, Joohyang; Kim, Yoo-Na; Lee, Yong Jae; Kim, Sunghoon; Kim, Sang Wun; Park, Su-Hyung; Lee, Jung-Yun 分享 收藏
Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4 olaparib，pembrolizumab和bevacizumab在BRCA野生型，铂类敏感性复发性卵巢癌女性中的三联维持治疗: 多中心，单臂II期研究OPEB-01/APGOT-OV4 Kim, Yoo-Na; Park, Boram; Kim, Jae Weon; Kim, Byoung Gie; Kim, Sang Wun; Kim, Hee Seung; Choi, Chel Hun; Lim, Myong Cheol; Ngoi, Natalie Y. L.; Tan, David S. P.; Lee, Jung-Yun 分享 收藏
分享 收藏
Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer 复发或晚期宫颈癌患者的综合基因组和免疫组织化学概况以及免疫治疗的结果 Kim, Yoo-Na; Lee, Kyunglim; Park, Eunhyang; Park, Junsik; Lee, Yong Jae; Nam, Eun Ji; Kim, Sang Wun; Kim, Sunghoon; Kim, Young Tae; Lee, Jung-Yun 分享 收藏
Investigation of PARP Inhibitor Resistance Based on Serially Collected Circulating Tumor DNA in Patients With BRCA-Mutated Ovarian Cancer 基于循环肿瘤DNA系列收集的BRCA突变卵巢癌患者PARP抑制剂耐药性研究 Kim, Yoo-Na; Shim, Yeeun; Seo, Jieun; Choi, Zisun; Lee, Yong Jae; Shin, Saeam; Kim, Sang Wun; Kim, Sunghoon; Choi, Jong Rak; Lee, Jung-Yun; Lee, Seung-Tae 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
TRIALS.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏